Pedro Luis Sánchez

Beta-blockers after invasively managed STEMI vs NSTEMI without reduced ejection fraction: a prespecified analysis from the REBOOT trial

Sergio Raposeiras‐Roubín, Manuel P. Anguita, Roberto Latini, Alberto Domínguez-Rodríguez et autres

es, it (code pays fourni par la source)

Growth Differentiation Factor 15 as a Biomarker of Cardiovascular Burden and Mortality in a Population-Based Cohort

Beatriz Martín-Carro, Leticia Nieto‐García, Clara Sánchez-Pablo, Alfonso Romero et autres

Growth differentiation factor 15 (GDF15) is a stress-responsive cytokine strongly associated with aging, multimorbidity, and cardiovascular disease. Although prior studies have established its prognostic value in high-risk populations, its role in the general population remains less defined. The aim of this study …

es (code pays fourni par la source)

Effect of beta blockers in acute and chronic coronary syndromes without reduced ejection fraction: a landmark analysis from the REBOOT trial

Xavier Rosselló, José A. Barrabés, Massimo Piepoli, Alberto Domínguez-Rodríguez et autres

AIMS: Current guidelines recommend beta-blocker therapy after myocardial infarction (MI) regardless of left ventricular ejection fraction (LVEF). However, recent trials question their benefit in patients with preserved LVEF. No study has yet compared beta-blocker effects during the acute coronary syndrome (ACS) phase …

es, it, gb, us (code pays fourni par la source)

AI-Powered DICOM Image Segmentation: A Collaborative Platform for Continuous Expert Feedback

Pablo Santos-Blázquez, Andrea Vázquez-Ingelmo, Alicia García-Holgado, Francisco José García-Peñalvo et autres

es, de (code pays fourni par la source)

External validation of atrial fibrillation risk scores in heart failure under continuous device surveillance

Federico García‐Rodeja Arias, Alberto Cordero, Leonardo Mejia Rincon, Begoña Cardeso et autres

es (code pays fourni par la source)

Effect of beta blocker withholding or withdrawal after myocardial infarction without reduced ejection fraction on ischaemic events: a post hoc analysis from the REBOOT trial

Xavier Rosselló, Pedro Luis Sánchez, Ruth Owen, Sergio Raposeiras‐Roubín et autres

BACKGROUND: Current guidelines recommend beta blockers after myocardial infarction (MI) regardless of left ventricular ejection fraction (LVEF), aiming to reduce reinfarction and ventricular arrhythmias. However, recent trials have challenged this practice in patients without reduced LVEF. Whether beta blocker withdrawal in these …

es, gb, it, us (code pays fourni par la source)

Prognostic value of right ventricular longitudinal strain assessed by multimodal imaging in amyloidosis: systematic review and meta-analysis

Javier Herrera-Flores, Robin W.M. Vernooij, Arjun Kumar Ghosh, Ashutosh Wechalekar et autres

Aims Amyloidosis is a progressive and often fatal disease, with right ventricular (RV) involvement emerging as critical determinant of outcomes. This meta-analysis sought to evaluate the prognostic significance of RV longitudinal strain parameters in patients with amyloidosis. Methods and results Eligible studies …

6079-572. BIOMARCADORES EMERGENTES EN LA ESTENOSIS AÓRTICA Y AMILOIDOSIS CARDIACA POR TRANSTIRRETINA: NUEVAS PERSPECTIVAS DE APLICACIÓN CLÍNICA

Gabriel Blanco-López, Emilio Blanco-López, Inés Perales-Sánchez, Germán Hernández-Fernández et autres

Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction

Borja Ibáñez, Roberto Latini, Xavier Rosselló, Alberto Domínguez‐Rodríguez et autres

BACKGROUND: Current guideline recommendations for the use of beta-blockers after myocardial infarction without reduced ejection fraction are based on trials conducted before routine reperfusion, invasive care, complete revascularization, and contemporary pharmacologic therapies became standard practice. METHODS: We conducted an open-label, randomized trial …

es, it, gb, mx, us (code pays fourni par la source)

Left Atrial Appendage Occlusion Compared to Anticoagulation in Patients Suffering from Atrial Fibrillation with Advanced Chronic Kidney Disease

Sergio López‐Tejero, Pablo Antúnez‐Muiños, Pilar Fraile Gómez, Fabián Blanco-Fernández et autres

Background/Objectives: Chronic kidney disease (CKD) is a significant risk factor for thrombogenic and bleeding events in patients with atrial fibrillation (AF). Left atrial appendage occlusion (LAAO) is increasingly utilized as an alternative to oral anticoagulation. We aimed to compare LAAO against medical …

es (code pays fourni par la source)

The Influence of Diabetes Mellitus and Kidney Dysfunction on Oxidative Stress, a Reflection of the Multisystem Interactions in Aortic Stenosis

Laura Mouriño-Álvarez, Inés Perales-Sánchez, Germán Hernández-Fernández, Gabriel Blanco-López et autres

Progression of aortic stenosis (AS) is aggravated by type 2 Diabetes Mellitus (T2DM) and kidney dysfunction (KD). Oxidative stress is one of the main mechanisms that triggers AS and is also disturbed among subjects with T2DM and KD. Consequently, we studied the …

es (code pays fourni par la source)

Association between Schizophrenia and Violence: The Cage of Psychosis

Angélica P. Escobar, Cristina López Fernández, Pedro Luis Sánchez, R. González Núñez et autres

Introduction In Spain, approximately 4% of the prison population suffers from severe mental disorders, with schizophrenia being more prevalent in this group compared to the general population. Although violent behavior is infrequent among individuals with schizophrenia, it holds significant clinical importance. Reoffending …

es (code pays fourni par la source)